Sources | Names Used |
---|---|
CTRPv2 | decitabine:navitoclax (2:1 mol/mol) |
PharmacoGx | decitabine:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | MBTD1 | CTRPv2 | pan-cancer | AAC | 0.33 | 3e-19 |
mRNA | ZBED4 | CTRPv2 | pan-cancer | AAC | 0.31 | 4e-18 |
mRNA | YPEL1 | CTRPv2 | pan-cancer | AAC | 0.27 | 9e-17 |
mRNA | ZNF8 | CTRPv2 | pan-cancer | AAC | 0.26 | 1e-14 |
mRNA | KMT5C | CTRPv2 | pan-cancer | AAC | 0.25 | 2e-14 |
mRNA | ZNF766 | CTRPv2 | pan-cancer | AAC | 0.25 | 3e-14 |
mRNA | GRIK5 | CTRPv2 | pan-cancer | AAC | 0.25 | 3e-14 |
mRNA | ARHGAP33 | CTRPv2 | pan-cancer | AAC | 0.25 | 3e-14 |
mRNA | SOX4 | CTRPv2 | pan-cancer | AAC | 0.23 | 6e-14 |
mRNA | PRR36 | CTRPv2 | pan-cancer | AAC | 0.24 | 9e-14 |